Dogecoin Cash, Inc. Amends 10-Q for Share Issuance Oversight
Ticker: DOGP · Form: 10-Q/A · Filed: Jan 2, 2025 · CIK: 1360442
| Field | Detail |
|---|---|
| Company | Dogecoin Cash, INC. (DOGP) |
| Form Type | 10-Q/A |
| Filed Date | Jan 2, 2025 |
| Risk Level | medium |
| Pages | 15 |
| Reading Time | 17 min |
| Key Dollar Amounts | $50,225, $10,045, $23,024.30, $33,333, $2,258.90 |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, filing-correction, shares
TL;DR
**DOGEC AMENDS 10-Q: Missed share issuance after Q3.**
AI Summary
Dogecoin Cash, Inc. filed an amendment (10-Q/A) on January 2, 2025, to its Form 10-Q for the period ending September 30, 2024. This amendment corrects an oversight where a share issuance that occurred after the reporting period was not included in the original filing dated December 31, 2024.
Why It Matters
This filing indicates a correction to previously reported financial information, which could affect the accuracy of the company's reported share structure and potentially investor understanding.
Risk Assessment
Risk Level: medium — Amendments to SEC filings can indicate past reporting errors or oversights, which may raise concerns about internal controls and the accuracy of previously disclosed information.
Key Numbers
- 9/30/2024 — Reporting Period End (The period covered by the amended 10-Q filing.)
- 12/31/2024 — Original Filing Date (Date the initial 10-Q was filed before the amendment.)
- 01/02/2025 — Amendment Filing Date (Date this 10-Q/A amendment was filed.)
Key Players & Entities
- Dogecoin Cash, Inc. (company) — Filer of the 10-Q/A
- 0001096906-25-000004.txt (document) — Accession number for the filing
- 20240930 (date) — Period ended for the 10-Q report
- 20250102 (date) — Filing date of the amendment
- 20241231 (date) — Original filing date of the 10-Q
FAQ
What specific share issuance was omitted from the original 10-Q filing?
The filing states that a share issuance(s) occurred after the reporting period ended September 30, 2024, but does not specify the exact number of shares or the transaction details in this amendment.
Why was the share issuance omitted from the original filing?
The omission was due to an oversight, as stated in the amendment.
When was the original Form 10-Q for the period ended September 30, 2024, filed?
The original Form 10-Q was filed on December 31, 2024.
What is the purpose of this 10-Q/A filing?
The purpose is to correct an omission related to a share issuance that occurred after the reporting period of September 30, 2024.
What is the company's former name?
The company was formerly known as Cannabis Sativa, Inc. and Ultra Sun Corp.
Filing Stats: 4,353 words · 17 min read · ~15 pages · Grade level 14.6 · Accepted 2025-01-02 14:09:47
Key Financial Figures
- $50,225 — as follows: David Tobias, President : $50,225 of debt shall be converted into 17,500,
- $10,045 — rrill, Financial Reporting Consultant : $10,045 of debt shall be converted into 3,505,5
- $23,024.30 — 23, 2024, Quick Capital, LLC converted $23,024.30 of the principal amount of a $33,333 no
- $33,333 — $23,024.30 of the principal amount of a $33,333 note dated May 22, 2024, along with $2,
- $2,258.90 — 333 note dated May 22, 2024, along with $2,258.90 in accrued interest, at a conversion pr
- $0.003896 — rued interest, at a conversion price of $0.003896 per share. This conversion resulted in
- $10,309 — aining principal balance on the note is $10,309.04, with no accrued or unpaid interest
- $78,400 — Cash used in operating activities was $78,400 in the nine months ended September 30,2
- $41,352 — We ended the third quarter of 2024 with $41,352 in cash on hand. The accompanying con
- $854,454 — of business. We incurred net losses of $854,454 and $995,109, respectively, for the nin
- $995,109 — We incurred net losses of $854,454 and $995,109, respectively, for the nine months ende
- $82,895,826 — 2023 and had an accumulated deficit of $82,895,826 as of September 30, 2024. The Company m
Filing Documents
- cbds-20240930.htm (10-Q/A) — 676KB
- cbds_ex31z1.htm (EX-31.1) — 12KB
- cbds_ex31z2.htm (EX-31.2) — 12KB
- cbds_ex32z1.htm (EX-32.1) — 4KB
- cbds_ex32z2.htm (EX-32.2) — 4KB
- 0001096906-25-000004.txt ( ) — 3034KB
- cbds-20240930_cal.xml (EX-101.CAL) — 29KB
- cbds-20240930_def.xml (EX-101.DEF) — 83KB
- cbds-20240930_lab.xml (EX-101.LAB) — 160KB
- cbds-20240930_pre.xml (EX-101.PRE) — 149KB
- cbds-20240930.xsd (EX-101.SCH) — 29KB
- cbds-20240930_htm.xml (XML) — 327KB
—FINANCIAL INFORMATION
PART I—FINANCIAL INFORMATION
Financial Statements
Item 1. Financial Statements. Attached after signature page.
Cybersecurity
Item 1C. Cybersecurity We recognize the critical importance of developing, implementing, and maintaining robust cybersecurity measures to safeguard our information systems and protect the confidentiality, integrity, and availability of our data. We currently have security measures in place to protect our clients, customers, employees, and vendor information and prevent data loss and other security breaches. We only use third party software for accounting, billing and payroll that has robust compliance and is actively involved in continuous assessment of risks from cybersecurity threats, including prevention, mitigation, detection, and remediation of cybersecurity incidents. Our CEO is responsible for overseeing our business operations and is responsible for day-to-day assessment and confers weekly with subsidiary webmaster to understand any risks from cybersecurity threats, including the prevention, mitigation, detection, and remediation of cybersecurity incidents. As our core operations are virtual, it is routine to undertake activities to prevent, detect, and minimize the effects of cybersecurity incidents, maintain business continuity, contingency, and have recovery plans for use in the event of a cybersecurity incident by the administering of local and cloud based back up of files and emails. We currently do not carry a cyber liability insurance policy but are evaluating whether to acquire one to mitigate any financial impact of a cybersecurity breach.
Management's Discussion and Analysis of Financial Condition and Results of Operations
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations. Certain statements in this Report constitute "forward-looking statements." Such forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause our actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. Factors that might cause such a difference include, among others, uncertainties relating to general economic and business conditions; industry trends; changes in demand for our products and services; uncertainties relating to customer plans and commitments and the timing of orders received from customers; announcements or changes in our pricing policies or that of our competitors; unanticipated delays in the development, market acceptance or installation of our products and services; changes in government regulations; availability of management and other key personnel; availability, terms, and deployment of capital; relationships with third-party equipment suppliers; and worldwide political stability and economic growth. The words "believe," "expect," "anticipate," "intend" and "plan" and similar expressions identify forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date the statement was made. 4 Results of Operations Three Months Ended September 30, 2024, compared with the Three Months Ended September 30, 2023 Three Months Ended A B A-B September 30, September 30, Change Change % 2024 2023 REVENUE $ 189,121 $ 271,207 $ (88,806) (27) % Cost of revenues 70,249 102,472 (36,506) (30) % Cost of sales % of total sales 37 % 38 % (1) % Gross profit 118,872 168,735 (52,300) (26) % Gross profit % of sales 63 % 62 % EXPENSES Pro
Quantitative and Qualitative Disclosures About Market Risk
Item 3. Quantitative and Qualitative Disclosures About Market Risk. Not required.
Controls and Procedures
Item 4. Controls and Procedures. Disclosure Controls and Procedures Conclusions of Management Regarding Effectiveness of Disclosure Controls and Procedures At the end of the period covered by this Quarterly Report on Form 10-Q, an evaluation was carried out under the supervision and with the participation of the Company's management, including the Chief Executive Officer ("CEO") and Chief Financial Officer ("CFO"), of the effectiveness of the design and operations of the Company's disclosure controls and procedures (as defined in Rule 13a – 15(e) and Rule 15d – 15(e) under the Exchange Act). Based on that evaluation, the CEO and the CFO have concluded that as of the end of the period covered by this report, the Company's disclosure controls and procedures were not effective as it was determined that there were material weaknesses affecting our disclosure controls and procedures. Management of the Company believes that these material weaknesses are due to the small size of the company's accounting staff. The small size of the Company's accounting staff may prevent adequate controls in the future, such as segregation of duties, due to the cost/benefit of remediation. To mitigate the current limited resources and limited employees, we rely heavily on direct management oversight of transactions, along with the use of external legal and accounting 7 professionals. As the Company grows, management expects to increase the number of employees, which will enable us to implement adequate segregation of duties within the internal control framework. Changes in Internal Control over Financial Reporting There was no change in our internal control over financial reporting during the quarter ended June 30, 2024, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
– OTHER INFORMATION
PART II – OTHER INFORMATION
Legal Proceedings
Item 1. Legal Proceedings. We are not a party to any material legal proceedings, and, to the best of our knowledge, no such legal proceedings have been threatened against us.
Risk Factors
Item 1A. Risk Factors Not required.
Unregistered Sales of Equity Securities and Use of Proceeds
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds. None
Defaults Upon Senior Securities
Item 3. Defaults Upon Senior Securities. None.
Mine Safety Disclosures
Item 4. Mine Safety Disclosures. Not applicable.
Other Information
Item 5. Other Information. None. 8
Exhibits
Item 6. Exhibits. The following documents are included as exhibits to this report: (a) Exhibits Exhibit Number SEC Reference Number Title of Document Notes 3.1 3 Articles of Incorporation (1) 3.2 3 Bylaws (1) 31.1 31 Section 302 Certification of Principal Executive Officer 31.2 31 Section 302 Certification of Principal Financial Officer 32.1 32 Section 1350 Certification of Principal Executive Officer 32.2 32 Section 1350 Certification of Principal Financial Officer 101.INS XBRL Instance Document (2) 101.SCH XBRL Taxonomy Extension Schema (2) 101.CAL XBRL Taxonomy Extension Calculation Linkbase (2) 101.DEF XBRL Taxonomy Extension Definition Linkbase (2) 101.LAB XBRL Taxonomy Extension Label Linkbase (2) 101.PRE XBRL Taxonomy Extension Presentation Linkbase (2) (1) Incorporated by reference to Exhibits 3.01 and 3.02 of the Company's Registration Statement on Form 10 filed January 28, 2009. (2) XBRL information is furnished and not filed for purposes of Sections 11 and 12 of the Securities Act of 1933 and Section 18 of the Securities Exchange Act of 1934, and is not subject to liability under those sections, is not part of any registration statement or prospectus to which it relates and is not incorporated or deemed to be incorporated by reference into any registration statement, prospectus or other document. 9
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Dogecoin Cash, Inc. Date: January 2, 2025 By: /s/ David Tobias David Tobias Principal Executive Officer Principal Financial Officer 10 DOGECOIN CASH, INC. Contents Page
FINANCIAL STATEMENTS - UNAUDITED – for the three and nine months ended September 30, 2024 and 2023
FINANCIAL STATEMENTS - UNAUDITED – for the three and nine months ended September 30, 2024 and 2023: Condensed consolidated balance sheets FS-2 Condensed consolidated statements of operations FS-3 Condensed consolidated statements of changes in stockholders' equity FS-4 Condensed consolidated statements of cash flows FS-5 Notes to condensed consolidated financial statements FS-6 through FS-17 FS-1 DOGECOIN CASH, INC. CONDENSED CONSOLIDATED BALANCE SHEETS - UNAUDITED September 30, December 31, 2024 2023 ASSETS Current Assets Cash $ 41,352 $ 83,762 Investment in equity securities, at fair value 18,000 66,000 Right of use asset - 10,232 Total Current Assets 59,352 159,994 Advances to related party 76,305 75,054 Property and equipment, net 2,231 2,436 Intangible assets, net 4,436 7,259 Goodwill 1,775,811 1,775,811 Total Assets $ 1,918,135 $ 2,020,554 LIABILITIES AND STOCKHOLDERS' EQUITY Current Liabilities Accounts payable and accrued expenses $ 126,808 $ 175,066 Operating lease liability, current - 10,232 Accrued interest - related parties 20,939 20,130 Fair value of convertible component in convertible loans 174,490 - Convertible notes payable 220,743 118,818 Notes payable to related parties 206,911 161,170 Total Current Liabilities 749,891 485,416 Long-term liabilities Stock payable 1,042,773 777,747 Total Liabilities 1,792,664 1,263,163 Commitments and contingencies (Notes 6 and 8) Stockholders' Equity Common stock $ 0.001 par value; 495,000,000 shares authorized; 110,030,284 and 88,814,037 shares issued and outstanding, respectively 110,030 88,815 Additional paid-in capital 81,593,515 81,392,196 Accumulated deficit ( 82,895,826 ) ( 82,083,492 ) Total Cannabis Sativa, Inc. Stockholders' Deficit ( 1,192,281 ) ( 602,481 ) Non-Controlling Interest 1,317,752 1,359,872 Total Stockholders'
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS For the Nine Months Ended September 30, 2024 and 2023 1. Organization and Summary of Significant Accounting Policies Nature of Business: Dogecoin Cash, Inc. (the "Company," "us", "we" or "our") was incorporated as Ultra Sun Corp. under the laws of Nevada in November 2004. On November 13, 2013, we changed our name to Cannabis Sativa, Inc. We operate through several subsidiaries including: PrestoCorp, Inc. ("PrestoCorp") Wild Earth Naturals, Inc. ("Wild Earth") Kubby Patent and Licenses Limited Liability Company ("KPAL") Hi Brands, International, Inc. ("Hi Brands") Eden Holdings LLC ("Eden"). PrestoCorp is a 51% owned subsidiary. Wild Earth, KPAL, Hi Brands, and Eden are wholly owned subsidiaries. At September 30, 2024 and December 31, 2023, PrestoCorp is the sole operating subsidiary. Our primary operations for the nine months ended September 30, 2024 were through PrestoCorp, which provides telemedicine online referral services for customers desiring medical marijuana cards in states where medical marijuana has been legalized. The Company is actively seeking new business opportunities for acquisition and is continually reviewing opportunities for product and brand development through our Wild Earth, Hi Brands, and KPAL subsidiaries. Basis of Presentation Operating results for the three and nine months ended September 30, 2024, may not be indicative of the results expected for the full year ending December 31, 2024. For further information, refer to the financial statements and notes thereto in our Annual Report on Form 10-K for the fiscal year ended December 31, 2023. The interim financial statements should be read in conjunction with audited financial statements and related footnotes set forth in our annual report filed on Form 10-K for the year ended December 31, 2023, as filed with the United States Securities and Exchange Commission on May 14, 2024. In the opinion of management, the accompan
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS For the Nine Months Ended September 30, 2024 and 2023 Going Concern: The Company has an accumulated deficit of $ 82,895,826 at September 30, 2024, which, among other factors, raises substantial doubt about the Company's ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent on the Company's ability to generate profitable operations in the future and/or to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they are due. Use of Estimates: The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America ("GAAP") requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Significant estimates and assumptions by management affect the allowance for doubtful accounts, the carrying value of long-lived assets (including goodwill and intangible assets), the provision for income taxes and related deferred tax accounts, certain accrued liabilities, revenue recognition, contingencies, and the value attributed to stock-based